Clinical Trials Logo

Stroke, Ischemic clinical trials

View clinical trials related to Stroke, Ischemic.

Filter by:

NCT ID: NCT06265753 Active, not recruiting - Stroke Clinical Trials

Gastrocinemius Function Massage on Lower Extemity Spasticity

Spasticity
Start date: January 23, 2024
Phase: N/A
Study type: Interventional

This study aimed to investigate gastrocinemius function massage on physical parameters of stroke patients.

NCT ID: NCT06251661 Recruiting - Stroke, Ischemic Clinical Trials

Cognitive Multi-sensory Rehabilitation on Upper Limb Function and Fatigue in Stroke

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

This interventional study aims to investigate the therapeutic efficacy of Cognitive multi-sensory rehabilitation (CMR) on upper limb function and fatigue in chronic stroke patients. The main question is: • Does cognitive multi-sensory rehabilitation significantly affect upper limb function and fatigue in stroke patients? Participants will be assigned into two groups. They will receive 12 sessions of study group CMR and traditional physical therapy and control group traditional physical Therapy rehabilitation. CMR 40 minutes immediately followed by 20 minutes of selected physical therapy program, three sessions per week for four weeks.

NCT ID: NCT06216457 Not yet recruiting - Stroke, Acute Clinical Trials

Comparative Observation of MeThinks AI Performance in Angiography and Non-Contrast CT Assessment.

COMPASS
Start date: February 1, 2024
Phase:
Study type: Observational

The goal of this prospective observational study is to assess the effectiveness and performance of Methinks AI stroke imaging software platform in acute Code Stroke patients, and as a comparator to study sites utilizing existing AI imaging stroke platforms. The main question[s] it aims to answer is: • Performance of and outcomes associated with the use of the Methinks AI stroke imaging medical device in real-world clinical practice.

NCT ID: NCT06214494 Not yet recruiting - Stroke, Ischemic Clinical Trials

Blood Flow Restricted High-Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare outcomes in chronic ischemic stroke survivors who can walk. The main question it aims to answer is: 1) How does blood flow restricted high-intensity treadmill training impact walking function? Participants will be separated into two groups and asked to walk on the treadmill for 75 minutes weekly. Only one group will experience blood flow restriction on their affected leg while walking on the treadmill. Researchers will then compare both groups to see if blood flow restriction training changes walking function, strength, and balance in this population.

NCT ID: NCT06213285 Enrolling by invitation - Atrial Fibrillation Clinical Trials

APPEND-CT Registry

APPEND-CT
Start date: February 2024
Phase:
Study type: Observational

The APPEND-CT registry is an investigator-driven multicenter retrospective observational database intended to compile cardiac CT follow-up data after Watchman FLX device implantation and function as a platform for answering clinical and research questions within LAAC follow-up. The derived studies should support therapeutic decision-making, improve risk-stratification in LAAC and help generate hypotheses for potential future clinical intervention trials.

NCT ID: NCT06200025 Completed - Stroke, Ischemic Clinical Trials

Virtual Reality in Aphasia Rehabilitation

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

Virtual reality-based aphasia rehabilitation has been shown to improve the language skills of individuals with aphasia in the chronic period after stroke. However, non-immersive or semi-immersive rehabilitation methods have often been adopted in the studies. Considering the importance of the visual given to the patient for naming, it can be thought that full immersive therapy may be more effective. Therefore, the aim of this study was to investigate the effect of cue-based aphasia naming therapy in a fully immersive virtual reality environment on aphasia severity and aphasia-related quality of life and to compare it with standard cue treatments.

NCT ID: NCT06196398 Recruiting - Stroke, Ischemic Clinical Trials

Effects of Medical Treatment of ICAS With Hemodynamic Disorders Based on MR-FFR

Start date: January 1, 2023
Phase:
Study type: Observational

This multicenter prospective cohort study aims to compare the difference in the effects of medical treatment within 1 year between the two groups of ICAS patients divided hemodynamically by Magnetic Resonance Fractional Flow Reserve. PC MRA will be applied for FFR measurement. The primary outcome is the composite of ischemic stroke or death related to the qualifying artery territory for 1 year.

NCT ID: NCT06170944 Not yet recruiting - Stroke, Ischemic Clinical Trials

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke

RICAS
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to explore the influence of chronic RIC on collateral status evaluated by DSA in ischemic stroke patients with LAA etiology.

NCT ID: NCT06165107 Completed - Stroke, Ischemic Clinical Trials

The Association Between Obesity-Related Indicators and Adverse Outcomes in Ischemic Stroke Patients

Start date: January 1, 2012
Phase:
Study type: Observational

The study population comprised patients experiencing acute first-ever ischaemic stroke, with diagnostic criteria established in accordance with the International Classification of Diseases, Ninth Revision. All subjects presented rigorous neuroimaging evidence, including head computed tomography and/or magnetic resonance imaging, which underwent review by two or more experienced neuroradiologists. Adverse outcomes were characterized as compliant endpoint events, encompassing mortality and recurrences. The primary outcome was adverse outcomes and the secondary outcome was recurrence-free survival (RFS).

NCT ID: NCT06155032 Recruiting - Stroke, Ischemic Clinical Trials

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Start date: January 4, 2024
Phase: N/A
Study type: Interventional

Endovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score >5. Thus, a sizeable fraction of patients with a minor stroke that do not undergo cerebrovascular screening may experience an early neurological deterioration (END) due to LVO, possibly leading to poor long-term functional outcome. However, whether these patients may still benefit from a rescue EVT is unknown, especially in a late window (>24 hours). In this study, the investigators assume that best medical management plus EVT might be superior than best medical management alone in a late window for minor stroke patients who have experienced an LVO and END. The primary objective of the study was to establish the safety and efficacy of EVT in a late window for minor stroke patients in the anterior circulation who experienced an LVO and END.